GW VITEK CO.,LTD. |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 568 KRW | -2.74% |
|
+0.71% | -10.69% |
| Sales 2022 | 52.53B 38.19M 3.06B | Sales 2023 | 47.92B 34.84M 2.79B | Capitalization | 39.78B 28.92M 2.32B |
|---|---|---|---|---|---|
| Net income 2022 | -8.36B -6.08M -487M | Net income 2023 | -14.93B -10.85M -869M | EV / Sales 2022 | 0.71 x |
| Net Debt 2022 | 7.04B 5.12M 410M | Net Debt 2023 | 8.27B 6.01M 481M | EV / Sales 2023 | 1 x |
| P/E ratio 2022 |
-3.94
x | P/E ratio 2023 |
-2.43
x | Employees | 117 |
| Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 78.65% |
More Fundamentals
* Assessed data
More news
| 1 day | -2.74% | ||
| 1 week | +0.71% | ||
| Current month | -17.44% | ||
| 1 month | -14.71% | ||
| 3 months | -11.39% | ||
| 6 months | -27.27% | ||
| Current year | -10.69% |
1 week
532.00
613.00
1 month
532.00710.00
Current year
510.00855.00
1 year
510.001 198.00
3 years
510.005 200.00
5 years
510.0015 450.00
10 years
510.0015 450.00
| Managers | Title | Age | Since |
|---|---|---|---|
Jae-Won Yang
CEO | Chief Executive Officer | 54 | 09/02/22 |
Kyung-Rok Noh
CTO | Chief Tech/Sci/R&D Officer | 58 | - |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Woon-Sang Jang
BRD | Director/Board Member | 56 | 28/11/21 |
Seong-Rok Oh
BRD | Director/Board Member | 58 | 28/11/21 |
Kyung-Rok Noh
CTO | Chief Tech/Sci/R&D Officer | 58 | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26/04/24 | 568 | -2.74% | 848,521 |
| 25/04/24 | 584 | -3.47% | 270,550 |
| 24/04/24 | 605 | -0.49% | 133,392 |
| 23/04/24 | 608 | +6.67% | 403,832 |
| 22/04/24 | 570 | +1.06% | 88,060 |
End-of-day quote Korea S.E., April 25, 2024
More quotes
GW Vitek Co Ltd, formerly A-Frontier Co Ltd, is a Korea-based company engaged in the sale of scientific equipment. The Company operates its business through two business segments. The Scientific Instruments segment mainly distributes scientific equipment and related consumables for experiments and research. The Bio segment mainly develops, manufactures and sells antibodies, new drugs using antibodies and diagnostic kits.
Sector
Office Equipment
Calendar
12/05/2024
- Q1 2024 Earnings Release (Projected)
| 1st Jan change | Capi. | |
|---|---|---|
| -10.69% | 37.74M | |
| -4.74% | 888M | |
| -3.82% | 501M | |
| -10.67% | 299M | |
| -13.39% | 205M | |
| -10.06% | 66.93M |
- Stock Market
- Equities
- A036180 Stock
